Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced B-cell Lymphoid Malignancies × Roflumilast × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 2 Motor Activity 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia 1 Advanced B-cell Lymphoid Malignancies 1

Interventions

Roflumilast 1 Prednisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01888952 2017-02-27

Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed

10 enrolled 4 charts

Advanced B-cell Lymphoid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡